We are live on
!
Find out more
PMSA
Patrick M. Sweeney & Associates Portfolio holdings
AUM
$156M
1-Year Est. Return
19.16%
This Fund
S&P 500
This Quarter
Est. Return
+11.57%
1 Year Est. Return
+19.16%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$109M
AUM Growth
–
Cap. Flow
+$102M
Cap. Flow
% of AUM
93.18%
Top 10 Holdings %
Top 10 Hldgs %
42%
Holding
127
New
127
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$7.38M |
| 2 |
Apple
AAPL
|
+$6.94M |
| 3 |
Merck
MRK
|
+$4.9M |
| 4 |
CVS Health
CVS
|
+$4.84M |
| 5 |
AbbVie
ABBV
|
+$3.85M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 30.64% |
| 2 | Financials | 16.5% |
| 3 | Industrials | 14.71% |
| 4 | Technology | 14.69% |
| 5 | Consumer Staples | 5.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Abbott
ABT
$180B
| $8.13M | 7.44% |
+73,901
| New | +$7.38M |
|
|
2
Apple
AAPL
$4.89T
| $7.23M | 6.61% |
+37,567
| New | +$6.94M |
|
|
3
CVS Health
CVS
$137B
| $5.37M | 4.91% |
+68,014
| New | +$4.84M |
|
|
4
Merck
MRK
$324B
| $5.15M | 4.71% |
+47,238
| New | +$4.9M |
|
5
Bank of America
BAC
$435B
| $4.33M | 3.96% |
+128,455
| New | +$3.74M |
|
|
6
AbbVie
ABBV
$458B
| $4.09M | 3.74% |
+26,377
| New | +$3.85M |
|
7
JPMorgan Chase
JPM
$939B
| $4.07M | 3.72% |
+23,940
| New | +$3.63M |
|
8
Microsoft
MSFT
$2.84T
| $3.73M | 3.42% |
+9,931
| New | +$3.53M |
|
9
Alphabet (Google) Class C
GOOG
$3.9T
| $2.04M | 1.86% |
+14,455
| New | +$1.96M |
|
10
Blackstone
BX
$104B
| $1.79M | 1.63% |
+13,640
| New | +$1.48M |
|
11
Visa
V
$677B
| $1.75M | 1.6% |
+6,728
| New | +$1.66M |
|
12
Costco
COST
$415B
| $1.7M | 1.56% |
+2,582
| New | +$1.53M |
|
13
Waste Management
WM
$95.9B
| $1.7M | 1.56% |
+9,504
| New | +$1.59M |
|
14
Eli Lilly
LLY
$1.07T
| $1.69M | 1.54% |
+2,897
| New | +$1.69M |
|
15
Amazon
AMZN
$2.5T
| $1.65M | 1.51% |
+10,866
| New | +$1.52M |
|
16
Invesco QQQ Trust
QQQ
$450B
| $1.58M | 1.45% |
+3,870
| New | +$1.47M |
|
17
Johnson & Johnson
JNJ
$635B
| $1.34M | 1.23% |
+8,562
| New | +$1.31M |
|
18
Berkshire Hathaway Class B
BRK.B
$1.07T
| $1.24M | 1.13% |
+3,475
| New | +$1.22M |
|
19
Pfizer
PFE
$140B
| $1.21M | 1.1% |
+41,889
| New | +$1.27M |
|
20
Union Pacific
UNP
$183B
| $1.2M | 1.1% |
+4,884
| New | +$1.07M |
|
21
PepsiCo
PEP
$186B
| $1.19M | 1.09% |
+6,993
| New | +$1.16M |
|
22
Home Depot
HD
$332B
| $1.13M | 1.03% |
+3,264
| New | +$1.01M |
|
23
Haleon
HLN
$43.1B
| $1.08M | 0.99% |
+131,635
| New | +$1.08M |
|
24
Caterpillar
CAT
$409B
| $1.07M | 0.98% |
+3,607
| New | +$936K |
|
25
UnitedHealth
UNH
$382B
| $1.03M | 0.94% |
+1,948
| New | +$1.04M |
|
Similar funds
BCM
IWA
CFG
BCM
AIS
BWM
MCA
TI
Patrick M. Sweeney & Associates's Q4 2023 Portfolio in Review
Q4 2023 is the first quarter with a 13F filing on record for Patrick M. Sweeney & Associates, which disclosed 127 positions worth $109M. Its ten largest holdings account for 42% of the portfolio.
Its largest position is Abbott: 73,901 shares worth $8.13M.
By sector, the portfolio is most concentrated in Healthcare at 31% of assets, followed by Financials and Industrials.
- Patrick M. Sweeney & Associates's largest Q4 2023 buy was Abbott: 73,901 shares worth $8.13M.
- Patrick M. Sweeney & Associates's ten largest holdings make up 42% of its $109M portfolio in Q4 2023.
- Patrick M. Sweeney & Associates disclosed 127 positions in Q4 2023, its first 13F filing on record.
Based on Patrick M. Sweeney & Associates's 13F filing for Q4 2023, filed 6 Feb 2024.